The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides)

Overview

The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides) offers an extensive online learning experience focused on the latest advances in oncology. This program features expert-led, case-based video presentations with accompanying slides to support clinical decision-making and reinforce oncology knowledge.

On-demand oncology education — accessible anytime, anywhere.

Format: Videos with Slides
Date Of Original Release: March 15, 2025

Agenda

This course provides detailed content covering a broad spectrum of oncology topics through multiple expert presentations:

• Molecular Genetics of Cancer — Marios Giannakis, MD, PhD
• Infections in Cancer Patients — Lindsey Baden, MD
• Opioid Prescribing for Cancer-Related Pain — Kate M. Lally, MD
• Communication – The Key to Excellence in End-of-Life Care — Eilann C. Santo, MD, MPH
• Biology of Hematopoietic Stem Cell Transplantation — Robert J. Soiffer, MD
• Biology of Acute Leukemia and Myelodysplastic Syndromes — Zuzana Tothova, MD, PhD
• The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now — Daniel J. DeAngelo, MD, PhD
• Myelodysplastic Syndrome — Eric S. Winer, MD
• Chronic Myelogenous Leukemia — Marlise R. Luskin, MD
• Myeloproliferative Syndromes — Joan-Chi How, MD
• Multiple Myeloma — Kenneth C. Anderson, MD
• Waldenstrom Macroglobulemia and Amyloidosis — Jorge J. Castillo, MD
• Low Grade Lymphomas — Caron A. Jacobson, MD
• Non-Hodgkin’s Lymphoma – Diffuse Large B-Cell and Burkitt — Eric D. Jacobsen, MD
• Non-Hodgkin Lymphoma – Mantle Cell and T-Cell — Eric D. Jacobsen, MD
• Hodgkin’s Lymphoma — Reid W. Merryman, MD
• Diagnosis and Treatment of CLL and Related B-Cell Malignancies — Matthew S. Davids, MD
• Head and Neck Cancer — Kartik Sehgal, MD
• Thyroid Cancer — Kartik Sehgal, MD
• Natural History, Screening, and Small Cell Lung Cancer — Jacob M. Sands, MD
• Management of Stage I-III – Non Small Cell Lung Cancer — Julia Rotow, MD
• Management of Metastatic – Non Small Cell Lung Cancer — Julia Rotow, MD
• Mesothelioma and Thymic Malignancies — David Kwiatkowski, MD, PhD
• Carcinoid and Neuroendocrine Tumors — Jennifer Ang Chan, MD
• Novel Approaches for the Management of Esophageal and Gastric Cancers — Peter C. Enzinger, MD
• Pancreatic Cancer — Brian M. Wolpin, MD
• Hepatobiliary Cancers Board Review — James M. Cleary, MD, PhD
• Management of Localized Colorectal Cancer — Douglas A. Rubinson, MD, PhD
• Metastatic Colorectal Cancer — Leah H. Biller, MD
• Gastrointestinal Cancer Genetics — Asaf Maoz, MD
• Prostate, Bladder, and Testicular Cancer — Mark M. Pomerantz, MD
• Key Updates in Urothelial Carcinoma — Bradley A. McGregor, MD
• Key Updates in Renal Cell Carcinoma — Bradley A. McGregor, MD
• Prostate Cancer Part I – Overview and Management of Localized Disease — Atish D. Choudhury, MD, PhD
• Prostate Cancer Part II – Management of Disseminated Prostate Cancer — Atish D. Choudhury, MD, PhD
• Melanoma — F. Stephen Hodi, MD
• Sarcomas and Gastrointestinal Stromal Tumors (GIST) — Suzanne George, MD
• Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer — Ursula A. Matulonis, MD
• Cervical and Endometrial Cancer — Panagiotis A. Konstantinopoulos, MD, PhD
• Neuro-oncology — David A. Reardon, MD
• Breast Cancer – Risk Factors, Genetics, Screening, and Prevention — Judy E. Garber, MD, MPH
• Multimodality Therapy for Early Stage Breast Cancer – Part 1 – Surgery and Radiation — Harold J. Burstein, MD, PhD
• Multimodality Therapy for Early Stage Breast Cancer – Part 2 – Systemic Therapy — Harold J. Burstein, MD, PhD
• Management of Metastatic Breast Cancer — Adrienne G. Waks, MD
• Breast Cancer Survivorship — Ann H. Partridge, MD, MPH

Speakers

The course features a comprehensive roster of oncology experts who provide evidence-based presentations covering multiple cancer types, treatment strategies, and supportive care topics. Each session is led by a specialized physician or researcher with clinical and academic expertise relevant to the content.

Target Audience

This course is tailored for oncology and hematology clinicians, oncology fellows, advanced practice providers, and other healthcare professionals seeking to update their clinical knowledge and strengthen their expertise in contemporary oncology management.

Why This Topic Matters

The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology 2025 (Videos + Slides) addresses critical updates in oncology care, helping clinicians maintain current knowledge in a rapidly evolving specialty. Oncology professionals benefit from this resource by reinforcing clinical decision-making with the latest evidence and expert insight.

As an on-demand offering from MedHub Central, this course supports lifelong learning and practical application in oncology, enhancing professional confidence and preparedness for both board review and daily clinical challenges.